Tender detail
Supply of Medicines and Medicinal Products II
Summary
The National Cancer Institute in Bratislava is procuring medicines and medicinal products for its hospital pharmacy over 24 months, divided into eight lots: carmustine formulations, cytostatic medicines, cabazitaxel, sacituzumab govitecan, avelumab, nivolumab with ipilimumab, and trastuzumab deruxtecan. The estimated total value is EUR 22,337,522.30. Delivery to the designated location, including unloading and packaging disposal, is part of the supply.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.